Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × Breakthrough Pain × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 169 Neoplasms 109 Polycystic Ovary Syndrome 91 Colorectal Neoplasms 72 Carcinoma, Hepatocellular 66 Prostatic Neoplasms 62 Stomach Neoplasms 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lung Neoplasms 44 Pancreatic Neoplasms 37 Pain, Postoperative 36 Carcinoma, Non-Small-Cell Lung 35 Pain 33 Head and Neck Neoplasms 32 Liver Neoplasms 31 Leukemia, Myeloid, Acute 28 Keratosis, Actinic 27 Colonic Neoplasms 27 Leiomyoma 26 Neoplasm Metastasis 25 Multiple Myeloma 24 Uterine Cervical Neoplasms 23 Lymphoma 23 Infertility 23 Brain Neoplasms 23 Recurrence 22 Papillomavirus Infections 20 Ovarian Neoplasms 20 Esophageal Neoplasms 19 Lymphoma, Follicular 18

Interventions

Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡